L
Lexicon Pharmaceuticals (LXRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and ... Read more
- USD1.07
- USD1.17
- USD1.07
- USD2.45
- 43.60%
- 31M
- 1.49M
- 4.51M
- 327M
- 0.28
- -33.10%
Stock News
1 hour ago
Airline stocks soar, lifted by Delta’s earnings beat and restored full-year guidance
MarketWatch
1 hour ago
North Carolina is America's Top State for Business in 2025, led by a strong workforce and economy
CNBC
2 hours ago
Super Micro Eyes European Expansion as AI Server Demand Takes Off
Yahoo
6 hours ago
3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
